1 / 31

Not Again!

Not Again!. Secondary Prevention of Future Cardiovascular Events J. Clay Hays, Jr., MD, FACC. 56 yr old insurance man. Presents with chest tightness after playing golf. Trying to walk 18 holes Hypertension on diuretics Not diabetic Unsure of lipids Smoker

tamber
Download Presentation

Not Again!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Not Again! Secondary Prevention of Future Cardiovascular Events J. Clay Hays, Jr., MD, FACC

  2. 56 yr old insurance man • Presents with chest tightness after playing golf. Trying to walk 18 holes • Hypertension on diuretics • Not diabetic • Unsure of lipids • Smoker • 82 year old mother with CHF, father died of stroke at 79 years old

  3. 56 year old man • Heart rate 100 beats/ min • BP 154/92 • 5’11’’; 230 lbs; BMI 32 • Soft right carotid bruit • Clear lungs • Regular rhythm with soft apical systolic murmur; soft s4

  4. 56 year old man • Obese • Can’t feel aorta, no bruits • 1+ pedal pulses • EKG sinus, nonspecific st-t wave changes • Trop 10 • What next?

  5. Diagnostics • 80% circumflex lesion with mild disease elsewhere • Placed 3.0x 12mm Taxus drug eluting stent • EF 45% with inferior wall hypokinesis • 30% right carotid lesion by ultrasound • Tchol 205, HDL 27, Trig 425

  6. What do you do?

  7. ASCVD • Coronary Artery Disease • Peripheral Arterial Disease • Carotid Arterial Disease • Atherosclerotic Aortic Disease

  8. Benefits of Aggressive Risk Factor Reduction • Improves survival • Reduces recurrent events • Reduces need for further intervention • Improves quality of life

  9. Smoking Goal Complete Cessation No exposure to environmental tobacco smoke

  10. Recommendations • Ask about tobacco use at every visit. I(B) • Advise user to quit. I(B) • Assist with counseling and a plan. I(B) • Arrange for followup, referral, or pharmacotherapy. I(B) • Avoid exposure at home or work. I(B)

  11. Blood Pressure Control Goal <140/90 Or <130/80 if diabetic or chronic kidney disease

  12. For all patients Weight control Increased activity Alcohol moderation Sodium reduction Increased fruit intake Increased veggies Low fat dairy Recommendations

  13. Recommendations For hypertensive patients • Initially treat with B blockers and/or ACEI • Add other drugs such as thiazides prn to achieve goal

  14. Lipid Management Goal LDL-C < 100 If Triglycerides are >200, non-HDL-C should be < 130 (Total cholesterol – HDL)

  15. For all patients • Start diet therapy I(B) • Reduce saturate fat (<7% of total calories) • Reduce trans-fatty acids • Reduce to total cholesterol <200 mg/dl • Add plant sterols (2g/d) and fiber (>10g/d) • Promote daily activity and weight reduction • Omega 3 (1g/d), more if trig are up. II(B)

  16. For lipid management • Assess fasting lipids within 24 hrs for patients with acute events. • Initiate medication before discharge according to : • LDL should be <100 (IA) and <70 is reasonable (IIaA) • See attached table

  17. Physical Activity Goal 30 minutes, 7 days per week (Minimum 5 days per week)

  18. Physical Activity All patients • Assess risk with physical activity history and/or exercise test to guide prescription • 30 to 60 mins of moderate intensity I(B) • 2 days/ week of resistance training. IIb (C) • Medical supervision for high risk patients I(B)

  19. Weight Management Goal BMI: 18.5 to 24.9kg/m2 Waist circumference: Men <40 inches, Women < 35 inches

  20. Weight management • Assess BMI on each visit • Encourage diet and exercise I(B) • Consider treatment strategies for metabolic syndrome I(B) • Initial goal to reduce 10% from baseline weight I(B)

  21. Diabetes Management Goal HbA1C <7%

  22. Antiplatelet agents • Aspirin 75 to 162 mg/d in all patients I(A) • For CABG, start ASA within 48 hrs to reduce chance of graft closure. 162 to 325mg for up to one year • Clopidogrel 75 mg/d with ASA for up to 1 year after an acute event

  23. Plavix and ASA after PCI • ASA 325 with Plavix 75 mg/day • 1 month with bare metal stents • 3 months with Cypher stents • 6 months with Taxus stents

  24. Warfarin • INR 2.0-3.0 • Paroxysmal atrial fib • Chronic atrial fib or flutter • Post MI patient with LV thrombus

  25. ACE Inhibitors • LV dysfunction <40% • Hypertension • Diabetes • Chronic Kidney disease • Optional for patients with normal LV function and good control of other risk factors

  26. Angiotensin Receptor Blockers • Intolerant to ACEI and have CHF or MI with EF <40% • Intolerant to ACEI • Combined with ACEI in pts with systolic-dysfunction heart failure

  27. Aldosterone Blockade • Post MI patients, without renal dysfunction or hyperkalemia, who are on ACEI and B blocker, have EF <40% and have diabetes or CHF. I(A)

  28. Beta blockers • All patients with MI, Acute coronary syndrome, or LV dysfunction • Continue indefinitely • Consider in other forms of vascular disease

  29. Influenza Vaccination • All patients with any form of ASCVD • Have you had yours?

  30. Questions?

More Related